Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth
Geographical Focus
United States, United Kingdom, Canada, Germany, Sweden
Industries Focus
- Healthcare
- Artificial Intelligence
- Digital Health
- Medical Devices
- Diagnostics
- Machine Learning
- Therapeutics
Investment Size:
1,000,000 to 10,000,000 USD
Investor Details Founded: 2021
Cross-Border Impact Ventures is an impact venture capital firm dedicated to revolutionizing health technology investments. The firm focuses on early-growth stage companies commercializing medical devices, diagnostics, therapeutics, and digital health innovations that leverage cutting-edge technologies like Artificial Intelligence (AI) and Machine Learning (ML). All innovations financed are relevant to women's, children's, and adolescents' health and are located in North America and Europe, with the ability to scale technologies to emerging markets. The firm is driven by the belief that good health should not be restricted by gender, age, race, wealth, or borders and seeks to expand access to its portfolio's world-class technologies inclusively and globally.
The firm's investment strategy targets health technology companies with global growth, high return, and impact potential. Its primary focus is on medical device, diagnostic, and digital health companies based in North America and Europe that are globally relevant, including in emerging markets. Target investments include healthcare software companies with $1 million to $10 million in revenue, as well as companies developing technologies that require regulatory approval and have at least one product that is CE Mark or FDA approved. The fund uses a gender lens to invest and works with portfolio companies to improve their diversity and ensure products reach a broader audience.
Since its launch in December 2021, Cross-Border Impact Ventures has made five investments in companies such as Pendulum, a health infrastructure software company using AI and ML to solve supply chain inefficiencies for essential medicines; Daye, a comprehensive gynecological care-as-a-service platform; mOm Incubators, a medical device company creating innovative portable incubators for neonatal care; Sonio, an AI-enabled software company providing fetal ultrasound practitioners with SaaS products; and OncoLens, a digital health platform offering oncology care management solutions. The firm's fundraising success demonstrates a large pool of investors who believe they can earn market returns while achieving ambitious impact targets with their dollars.
Requirements
- Companies addressing health needs of women, children, and adolescents
- Global growth potential
- High return and impact potential
- Located in North America or Europe with ability to scale to emerging markets
- Healthcare software companies with $1 million to $10 million in revenue
- Companies developing technologies requiring regulatory approval with at least one product that is CE Mark or FDA approved
- Diverse management teams
- Products that reach a broad audience
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Pendulum
- Daye
- mOm Incubators
- Sonio
- OncoLens
Mentioned In
-
$24.95
-
$19.95
-
$49.95
-
$24.95
-
$19.95
-
$39.95
Claim this Investor
Are you an official representative of Cross-Border Impact Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim